Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States

Net Cash Flow Breakdown

FY2025 FY2010 FY2009

Total Cash from Operations: $54.1M

Line Item	Value	% of Total
Working Capital	$25.5M	47.2%
Net Cash Flow	$28.6M	52.8%